Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 26Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Taro Pharmaceutical Industries

02 2Bal Pharma

03 12care4 ApS

04 2ANI Pharmaceuticals Inc

05 3Accord healthcare

06 2Acme Lifetech

07 7Actavis Inc

08 3AiPing Pharmaceutical Inc

09 2Alcon Inc

10 1Altaire Pharmaceuticals

11 6Amneal Pharmaceuticals

12 1Amring Pharma

13 1Arya Pharma (Pty) Ltd

14 2Auro Pharma Inc

15 3Aurobindo Pharma Limited

16 1BIOMED 2002 INC

17 3Barr Laboratories

18 7Bayer AG

19 12Bio Labs

20 1Biodeal Pharmaceuticals

21 3Bluefish Pharmaceuticals AB

22 3Carlsbad Technology

23 3Chartwell Pharmaceuticals llc

24 1Cifarma

25 1DEPOMED INC

26 3Drug Medical Supplies Ltd.

27 2ENDO OPERATIONS

28 1Eloge

29 1Enlie Pharmaceutical Joint Stock Company

30 1FDC

31 4Focelite

32 1Fosun Pharmaceutical

33 2Halewood Laboratories Pvt. Ltd

34 2Hanlim Pharmaceuticals Inc

35 3Hexal AG

36 3Hikma Pharmaceuticals

37 3IVAX Pharmaceuticals Inc

38 2JAMP PHARMA

39 3KRKA Sweden AB

40 1Key Therapeutics

41 1LABORATOIRE RIVA INC.

42 2Laboratorios Salvat

43 2MARCAN PHARMACEUTICALS INC

44 1MEDEXUS PHARMACEUTICALS INC.

45 1MINT PHARMACEUTICALS INC

46 1Medivision

47 3Natco Pharma

48 2Navamedic

49 2Neopharma

50 1Nora Pharma

51 2NoroBio Pharmaceutical

52 3Nostrum Laboratories

53 3Novartis Pharmaceuticals Corporation

54 3Novell Pharmaceutical Laboratories

55 1ORIFARM GROUP AS

56 1Opes Health Care

57 2PRO DOC LIMITEE

58 2PRO.MED.CS Praha

59 3Paranova Group AS

60 6Pharmascience Inc.

61 3Pliva Hrvatska

62 1RANBAXY LABORATORIES LIMITED

63 2Remedy Pharma

64 6Rising Pharmaceuticals Inc

65 1Rubicon Research

66 2SA Alcon Couvreur NV

67 1SANIS HEALTH INC

68 2SIVEM PHARMACEUTICALS ULC

69 8Sandoz B2B

70 1ScieGen Pharmaceuticals

71 6Sun Pharmaceutical Industries Limited

72 6Teva Pharmaceutical Industries

73 1The J. Molner Company

74 2Umedica Laboratories

75 3Unique Biotech Limited

76 4Viatris

77 1World Medicine

78 5XYZ Pharma

79 1Yangtze River Pharmaceutical Group

80 2Yiling Pharmaceutical

81 3Zim Laboratories

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.

Regulatory Info : Generic

Registration Country : India

Ciprofloxacin Hydrochloride

Brand Name : Ultraflox

Dosage Form : Tablet

Dosage Strength : 250MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

BalPharma

02

arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPROFLOXACIN HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Packaging :

Approval Date : 2004-10-06

Application Number : 76912

Regulatory Info : DISCN

Registration Country : USA

blank

03

arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPROFLOXACIN HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 500MG BASE

Packaging :

Approval Date : 2004-10-06

Application Number : 76912

Regulatory Info : DISCN

Registration Country : USA

blank

04

arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPROFLOXACIN HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 750MG BASE

Packaging :

Approval Date : 2004-10-06

Application Number : 76912

Regulatory Info : DISCN

Registration Country : USA

blank

05

arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)

Brand Name : TARO-CIPROFLOXACIN/DEXAMETHASONE

Dosage Form : SUSPENSION

Dosage Strength : 0.3%/W/V

Packaging : 7.5ML

Approval Date :

Application Number : 2481901

Regulatory Info : Prescription

Registration Country : Canada

blank

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBal Pharma, leading manufacturer of niche & specialty API, Intermediates and Finished Formulations.

Regulatory Info : Generic

Registration Country : India

Ciprofloxacin Hydrochloride

Brand Name : Ultraflox

Dosage Form : Tablet

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

BalPharma

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPROFLOXACIN HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Packaging :

Approval Date : 2004-06-09

Application Number : 74124

Regulatory Info : DISCN

Registration Country : USA

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPROFLOXACIN HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 500MG BASE

Packaging :

Approval Date : 2004-06-09

Application Number : 74124

Regulatory Info : DISCN

Registration Country : USA

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPRO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 250MG BASE

Packaging :

Approval Date : 1987-10-22

Application Number : 19537

Regulatory Info : RX

Registration Country : USA

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPRO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 500MG BASE

Packaging :

Approval Date : 1987-10-22

Application Number : 19537

Regulatory Info : RX

Registration Country : USA

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPRO

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 750MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1987-10-22

Application Number : 19537

Regulatory Info : DISCN

Registration Country : USA

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPRO XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 212.6MG;EQ 287.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2002-12-13

Application Number : 21473

Regulatory Info : DISCN

Registration Country : USA

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPRO XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 425.2MG;EQ 574.9MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2003-08-28

Application Number : 21473

Regulatory Info : DISCN

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPRO XR

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Dosage Strength : 212.6MG; EQ 287.5MG BASE

Packaging :

Approval Date :

Application Number : 21554

Regulatory Info :

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CIPRO XR

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Dosage Strength : 425.2MG; EQ 574.9MG BASE

Packaging :

Approval Date :

Application Number : 21554

Regulatory Info :

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : PROQUIN XR

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 500MG BASE

Packaging :

Approval Date : 2005-05-19

Application Number : 21744

Regulatory Info : DISCN

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CETRAXAL

Dosage Form : SOLUTION/DROPS;OTIC

Dosage Strength : EQ 0.2% BASE

Packaging :

Approval Date : 2009-05-01

Application Number : 21918

Regulatory Info : RX

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CILOXAN

Dosage Form : SOLUTION/DROPS;OPHTHALMIC

Dosage Strength : EQ 0.3% BASE

Packaging :

Approval Date : 1990-12-31

Application Number : 19992

Regulatory Info : RX

Registration Country : USA

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE

Brand Name : CILOXAN

Dosage Form : OINTMENT;OPHTHALMIC

Dosage Strength : EQ 0.3% BASE

Packaging :

Approval Date : 1998-03-30

Application Number : 20369

Regulatory Info : RX

Registration Country : USA

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE

Brand Name : CIPRO HC

Dosage Form : SUSPENSION/DROPS;OTIC

Dosage Strength : EQ 0.2% BASE;1%

Packaging :

Approval Date : 1998-02-10

Application Number : 20805

Regulatory Info : RX

Registration Country : USA

blank